Dissecting Sex‐Specific Pathology in K18‐hACE2 Transgenic Mice Infected With Different SARS‐CoV‐2 Variants Article Swipe
Elysia A. Masters
,
Weichun Tang
,
Insung Kang
,
Martina Košíková
,
John H. Hanks
,
Lana Elkins
,
Hyung‐Joon Kwon
,
Uriel Ortega‐Rodriguez
,
Binsheng Gong
,
Kelly E. Mercer
,
Hang Xie
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/jmv.70506
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1002/jmv.70506
Sex‐biased differences in COVID‐19 outcomes in relation to individual SARS‐CoV‐2 variants are not well understood. In this study, lungs and nasal cavities of age‐matched female and male K18‐hACE2 transgenic mice were collected for dissecting sex‐specific differences in pathology after infection of SARS‐CoV‐2 614 G, Delta, or Omicron variant. Overall, Delta infection induced the most severe inflammation and pathology in nasal cavity and lung followed by the 614 G, then Omicron variant. Sex differences in host responses to SARS‐CoV‐2 infection were variant‐specific. Delta‐infected males showed increased pulmonary infiltration of CD163+ “M2” macrophages, Ly6G+ neutrophils, and NKR‐P1C + NK cells during early onset of infection, and elevated lung inflammatory cytokines such as IL‐10, IL‐6, and IP‐10 than Delta‐infected females. Conversely, females had increased lung CD4 + T cell recruitment after Omicron infection and significantly elevated lung MCP‐1 secretion after Delta infection than males. Lung spatial transcriptomics data revealed that Delta‐infected females had enriched gene pathways related to humoral immune response and interferon signaling, while males had enriched pathways associated with extracellular matrix production, chemokine signaling, and cell chemotaxis. Taken together, this study highlights the complex infection dynamics with respect to individual SARS‐CoV‐2 variants and underscores the importance of sex as a confounding factor for COVID‐19 pathology.
Related Topics
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/jmv.70506
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70506
- OA Status
- hybrid
- References
- 52
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4412541463
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4412541463Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/jmv.70506Digital Object Identifier
- Title
-
Dissecting Sex‐Specific Pathology in K18‐hACE2 Transgenic Mice Infected With Different SARS‐CoV‐2 VariantsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-01Full publication date if available
- Authors
-
Elysia A. Masters, Weichun Tang, Insung Kang, Martina Košíková, John H. Hanks, Lana Elkins, Hyung‐Joon Kwon, Uriel Ortega‐Rodriguez, Binsheng Gong, Kelly E. Mercer, Hang XieList of authors in order
- Landing page
-
https://doi.org/10.1002/jmv.70506Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70506Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
hybridOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70506Direct OA link when available
- Concepts
-
Biology, Immunology, Chemokine, Immune system, Lung, Virology, Medicine, Internal medicineTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
52Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4412541463 |
|---|---|
| doi | https://doi.org/10.1002/jmv.70506 |
| ids.doi | https://doi.org/10.1002/jmv.70506 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40686017 |
| ids.openalex | https://openalex.org/W4412541463 |
| fwci | 0.0 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000818 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Animals |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D005260 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Female |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D008822 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Mice, Transgenic |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D008297 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Male |
| mesh[4].qualifier_ui | Q000473 |
| mesh[4].descriptor_ui | D000086382 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | pathology |
| mesh[4].descriptor_name | COVID-19 |
| mesh[5].qualifier_ui | Q000821 |
| mesh[5].descriptor_ui | D000086382 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | virology |
| mesh[5].descriptor_name | COVID-19 |
| mesh[6].qualifier_ui | Q000276 |
| mesh[6].descriptor_ui | D000086382 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | immunology |
| mesh[6].descriptor_name | COVID-19 |
| mesh[7].qualifier_ui | Q000235 |
| mesh[7].descriptor_ui | D000086382 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | genetics |
| mesh[7].descriptor_name | COVID-19 |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D051379 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Mice |
| mesh[9].qualifier_ui | Q000473 |
| mesh[9].descriptor_ui | D008168 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | pathology |
| mesh[9].descriptor_name | Lung |
| mesh[10].qualifier_ui | Q000821 |
| mesh[10].descriptor_ui | D008168 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | virology |
| mesh[10].descriptor_name | Lung |
| mesh[11].qualifier_ui | Q000276 |
| mesh[11].descriptor_ui | D008168 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | immunology |
| mesh[11].descriptor_name | Lung |
| mesh[12].qualifier_ui | Q000235 |
| mesh[12].descriptor_ui | D000086402 |
| mesh[12].is_major_topic | True |
| mesh[12].qualifier_name | genetics |
| mesh[12].descriptor_name | SARS-CoV-2 |
| mesh[13].qualifier_ui | Q000472 |
| mesh[13].descriptor_ui | D000086402 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | pathogenicity |
| mesh[13].descriptor_name | SARS-CoV-2 |
| mesh[14].qualifier_ui | Q000276 |
| mesh[14].descriptor_ui | D000086402 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | immunology |
| mesh[14].descriptor_name | SARS-CoV-2 |
| mesh[15].qualifier_ui | Q000235 |
| mesh[15].descriptor_ui | D000085962 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | genetics |
| mesh[15].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[16].qualifier_ui | Q000378 |
| mesh[16].descriptor_ui | D016207 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | metabolism |
| mesh[16].descriptor_name | Cytokines |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D012737 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Sex Factors |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D004195 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Disease Models, Animal |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D006801 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Humans |
| mesh[20].qualifier_ui | Q000276 |
| mesh[20].descriptor_ui | D008264 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | immunology |
| mesh[20].descriptor_name | Macrophages |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D000818 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Animals |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D005260 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Female |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D008822 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Mice, Transgenic |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D008297 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Male |
| mesh[25].qualifier_ui | Q000473 |
| mesh[25].descriptor_ui | D000086382 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | pathology |
| mesh[25].descriptor_name | COVID-19 |
| mesh[26].qualifier_ui | Q000821 |
| mesh[26].descriptor_ui | D000086382 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | virology |
| mesh[26].descriptor_name | COVID-19 |
| mesh[27].qualifier_ui | Q000276 |
| mesh[27].descriptor_ui | D000086382 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | immunology |
| mesh[27].descriptor_name | COVID-19 |
| mesh[28].qualifier_ui | Q000235 |
| mesh[28].descriptor_ui | D000086382 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | genetics |
| mesh[28].descriptor_name | COVID-19 |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D051379 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Mice |
| mesh[30].qualifier_ui | Q000473 |
| mesh[30].descriptor_ui | D008168 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | pathology |
| mesh[30].descriptor_name | Lung |
| mesh[31].qualifier_ui | Q000821 |
| mesh[31].descriptor_ui | D008168 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | virology |
| mesh[31].descriptor_name | Lung |
| mesh[32].qualifier_ui | Q000276 |
| mesh[32].descriptor_ui | D008168 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | immunology |
| mesh[32].descriptor_name | Lung |
| mesh[33].qualifier_ui | Q000235 |
| mesh[33].descriptor_ui | D000086402 |
| mesh[33].is_major_topic | True |
| mesh[33].qualifier_name | genetics |
| mesh[33].descriptor_name | SARS-CoV-2 |
| mesh[34].qualifier_ui | Q000472 |
| mesh[34].descriptor_ui | D000086402 |
| mesh[34].is_major_topic | True |
| mesh[34].qualifier_name | pathogenicity |
| mesh[34].descriptor_name | SARS-CoV-2 |
| mesh[35].qualifier_ui | Q000276 |
| mesh[35].descriptor_ui | D000086402 |
| mesh[35].is_major_topic | True |
| mesh[35].qualifier_name | immunology |
| mesh[35].descriptor_name | SARS-CoV-2 |
| mesh[36].qualifier_ui | Q000235 |
| mesh[36].descriptor_ui | D000085962 |
| mesh[36].is_major_topic | True |
| mesh[36].qualifier_name | genetics |
| mesh[36].descriptor_name | Angiotensin-Converting Enzyme 2 |
| mesh[37].qualifier_ui | Q000378 |
| mesh[37].descriptor_ui | D016207 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | metabolism |
| mesh[37].descriptor_name | Cytokines |
| mesh[38].qualifier_ui | |
| mesh[38].descriptor_ui | D012737 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | |
| mesh[38].descriptor_name | Sex Factors |
| mesh[39].qualifier_ui | |
| mesh[39].descriptor_ui | D004195 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | |
| mesh[39].descriptor_name | Disease Models, Animal |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D006801 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Humans |
| mesh[41].qualifier_ui | Q000276 |
| mesh[41].descriptor_ui | D008264 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | immunology |
| mesh[41].descriptor_name | Macrophages |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D000818 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Animals |
| mesh[43].qualifier_ui | |
| mesh[43].descriptor_ui | D005260 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | |
| mesh[43].descriptor_name | Female |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D008822 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Mice, Transgenic |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D008297 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Male |
| mesh[46].qualifier_ui | Q000473 |
| mesh[46].descriptor_ui | D000086382 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | pathology |
| mesh[46].descriptor_name | COVID-19 |
| mesh[47].qualifier_ui | Q000821 |
| mesh[47].descriptor_ui | D000086382 |
| mesh[47].is_major_topic | True |
| mesh[47].qualifier_name | virology |
| mesh[47].descriptor_name | COVID-19 |
| mesh[48].qualifier_ui | Q000276 |
| mesh[48].descriptor_ui | D000086382 |
| mesh[48].is_major_topic | True |
| mesh[48].qualifier_name | immunology |
| mesh[48].descriptor_name | COVID-19 |
| mesh[49].qualifier_ui | Q000235 |
| mesh[49].descriptor_ui | D000086382 |
| mesh[49].is_major_topic | True |
| mesh[49].qualifier_name | genetics |
| mesh[49].descriptor_name | COVID-19 |
| type | article |
| title | Dissecting Sex‐Specific Pathology in K18‐hACE2 Transgenic Mice Infected With Different SARS‐CoV‐2 Variants |
| biblio.issue | 7 |
| biblio.volume | 97 |
| biblio.last_page | e70506 |
| biblio.first_page | e70506 |
| topics[0].id | https://openalex.org/T10118 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2725 |
| topics[0].subfield.display_name | Infectious Diseases |
| topics[0].display_name | SARS-CoV-2 and COVID-19 Research |
| topics[1].id | https://openalex.org/T10041 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9986000061035156 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2725 |
| topics[1].subfield.display_name | Infectious Diseases |
| topics[1].display_name | COVID-19 Clinical Research Studies |
| topics[2].id | https://openalex.org/T11668 |
| topics[2].field.id | https://openalex.org/fields/24 |
| topics[2].field.display_name | Immunology and Microbiology |
| topics[2].score | 0.9836999773979187 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2403 |
| topics[2].subfield.display_name | Immunology |
| topics[2].display_name | interferon and immune responses |
| is_xpac | False |
| apc_list.value | 4020 |
| apc_list.currency | USD |
| apc_list.value_usd | 4020 |
| apc_paid.value | 4020 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 4020 |
| concepts[0].id | https://openalex.org/C86803240 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7544409036636353 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[0].display_name | Biology |
| concepts[1].id | https://openalex.org/C203014093 |
| concepts[1].level | 1 |
| concepts[1].score | 0.651611864566803 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[1].display_name | Immunology |
| concepts[2].id | https://openalex.org/C13373296 |
| concepts[2].level | 3 |
| concepts[2].score | 0.641940712928772 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q421866 |
| concepts[2].display_name | Chemokine |
| concepts[3].id | https://openalex.org/C8891405 |
| concepts[3].level | 2 |
| concepts[3].score | 0.6063905358314514 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[3].display_name | Immune system |
| concepts[4].id | https://openalex.org/C2777714996 |
| concepts[4].level | 2 |
| concepts[4].score | 0.5808139443397522 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7886 |
| concepts[4].display_name | Lung |
| concepts[5].id | https://openalex.org/C159047783 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3752710521221161 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7215 |
| concepts[5].display_name | Virology |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.1591288447380066 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.11085686087608337 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| keywords[0].id | https://openalex.org/keywords/biology |
| keywords[0].score | 0.7544409036636353 |
| keywords[0].display_name | Biology |
| keywords[1].id | https://openalex.org/keywords/immunology |
| keywords[1].score | 0.651611864566803 |
| keywords[1].display_name | Immunology |
| keywords[2].id | https://openalex.org/keywords/chemokine |
| keywords[2].score | 0.641940712928772 |
| keywords[2].display_name | Chemokine |
| keywords[3].id | https://openalex.org/keywords/immune-system |
| keywords[3].score | 0.6063905358314514 |
| keywords[3].display_name | Immune system |
| keywords[4].id | https://openalex.org/keywords/lung |
| keywords[4].score | 0.5808139443397522 |
| keywords[4].display_name | Lung |
| keywords[5].id | https://openalex.org/keywords/virology |
| keywords[5].score | 0.3752710521221161 |
| keywords[5].display_name | Virology |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.1591288447380066 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.11085686087608337 |
| keywords[7].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1002/jmv.70506 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S49828768 |
| locations[0].source.issn | 0146-6615, 1096-9071 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0146-6615 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Medical Virology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70506 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Medical Virology |
| locations[0].landing_page_url | https://doi.org/10.1002/jmv.70506 |
| locations[1].id | pmid:40686017 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of medical virology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40686017 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:12277941 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Med Virol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12277941 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5016127268 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-9981-624X |
| authorships[0].author.display_name | Elysia A. Masters |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[0].affiliations[0].raw_affiliation_string | Division of Systems Biology, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA |
| authorships[0].institutions[0].id | https://openalex.org/I1304557061 |
| authorships[0].institutions[0].ror | https://ror.org/05jmhh281 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | National Center for Toxicological Research |
| authorships[0].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[0].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[0].institutions[1].type | government |
| authorships[0].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[0].institutions[1].country_code | US |
| authorships[0].institutions[1].display_name | United States Food and Drug Administration |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Elysia A. Masters |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Division of Systems Biology, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA |
| authorships[1].author.id | https://openalex.org/A5060123482 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0796-6038 |
| authorships[1].author.display_name | Weichun Tang |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[1].affiliations[0].raw_affiliation_string | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[1].institutions[0].id | https://openalex.org/I1318287680 |
| authorships[1].institutions[0].ror | https://ror.org/02nr3fr97 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Center for Biologics Evaluation and Research |
| authorships[1].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[1].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[1].institutions[1].type | government |
| authorships[1].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | United States Food and Drug Administration |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Weichun Tang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[2].author.id | https://openalex.org/A5089472152 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Insung Kang |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[2].affiliations[0].raw_affiliation_string | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[2].institutions[0].id | https://openalex.org/I1318287680 |
| authorships[2].institutions[0].ror | https://ror.org/02nr3fr97 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Center for Biologics Evaluation and Research |
| authorships[2].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[2].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[2].institutions[1].type | government |
| authorships[2].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[2].institutions[1].country_code | US |
| authorships[2].institutions[1].display_name | United States Food and Drug Administration |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Insung Kang |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[3].author.id | https://openalex.org/A5046044715 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1433-3343 |
| authorships[3].author.display_name | Martina Košíková |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[3].affiliations[0].raw_affiliation_string | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[3].institutions[0].id | https://openalex.org/I1318287680 |
| authorships[3].institutions[0].ror | https://ror.org/02nr3fr97 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Center for Biologics Evaluation and Research |
| authorships[3].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[3].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[3].institutions[1].type | government |
| authorships[3].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[3].institutions[1].country_code | US |
| authorships[3].institutions[1].display_name | United States Food and Drug Administration |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Martina Kosikova |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[4].author.id | https://openalex.org/A5103414124 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | John H. Hanks |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[4].affiliations[0].raw_affiliation_string | Division of Neurotoxicology, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA |
| authorships[4].affiliations[1].raw_affiliation_string | Toxicologic Pathology Associates Jefferson Arkansas USA |
| authorships[4].institutions[0].id | https://openalex.org/I1304557061 |
| authorships[4].institutions[0].ror | https://ror.org/05jmhh281 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | National Center for Toxicological Research |
| authorships[4].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[4].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[4].institutions[1].type | government |
| authorships[4].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[4].institutions[1].country_code | US |
| authorships[4].institutions[1].display_name | United States Food and Drug Administration |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Jennifer H. Hanks |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Division of Neurotoxicology, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA, Toxicologic Pathology Associates Jefferson Arkansas USA |
| authorships[5].author.id | https://openalex.org/A5119031488 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Lana Elkins |
| authorships[5].affiliations[0].raw_affiliation_string | Toxicologic Pathology Associates Jefferson Arkansas USA |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Lana Elkins |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Toxicologic Pathology Associates Jefferson Arkansas USA |
| authorships[6].author.id | https://openalex.org/A5102158523 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Hyung‐Joon Kwon |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[6].affiliations[0].raw_affiliation_string | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[6].institutions[0].id | https://openalex.org/I1318287680 |
| authorships[6].institutions[0].ror | https://ror.org/02nr3fr97 |
| authorships[6].institutions[0].type | facility |
| authorships[6].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Center for Biologics Evaluation and Research |
| authorships[6].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[6].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[6].institutions[1].type | government |
| authorships[6].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[6].institutions[1].country_code | US |
| authorships[6].institutions[1].display_name | United States Food and Drug Administration |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Hyung‐Joon Kwon |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[7].author.id | https://openalex.org/A5008768220 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-1700-357X |
| authorships[7].author.display_name | Uriel Ortega‐Rodriguez |
| authorships[7].countries | US |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[7].affiliations[0].raw_affiliation_string | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[7].institutions[0].id | https://openalex.org/I1318287680 |
| authorships[7].institutions[0].ror | https://ror.org/02nr3fr97 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[7].institutions[0].country_code | US |
| authorships[7].institutions[0].display_name | Center for Biologics Evaluation and Research |
| authorships[7].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[7].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[7].institutions[1].type | government |
| authorships[7].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[7].institutions[1].country_code | US |
| authorships[7].institutions[1].display_name | United States Food and Drug Administration |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Uriel Ortega‐Rodriguez |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[8].author.id | https://openalex.org/A5042778420 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-8724-5435 |
| authorships[8].author.display_name | Binsheng Gong |
| authorships[8].countries | US |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[8].affiliations[0].raw_affiliation_string | Division of Bioinformatics and Biostatistics, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA |
| authorships[8].institutions[0].id | https://openalex.org/I1304557061 |
| authorships[8].institutions[0].ror | https://ror.org/05jmhh281 |
| authorships[8].institutions[0].type | facility |
| authorships[8].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[8].institutions[0].country_code | US |
| authorships[8].institutions[0].display_name | National Center for Toxicological Research |
| authorships[8].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[8].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[8].institutions[1].type | government |
| authorships[8].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[8].institutions[1].country_code | US |
| authorships[8].institutions[1].display_name | United States Food and Drug Administration |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Binsheng Gong |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Division of Bioinformatics and Biostatistics, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA |
| authorships[9].author.id | https://openalex.org/A5026229305 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Kelly E. Mercer |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[9].affiliations[0].raw_affiliation_string | Division of Systems Biology, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA |
| authorships[9].institutions[0].id | https://openalex.org/I1304557061 |
| authorships[9].institutions[0].ror | https://ror.org/05jmhh281 |
| authorships[9].institutions[0].type | facility |
| authorships[9].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1304557061, https://openalex.org/I1320320070 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | National Center for Toxicological Research |
| authorships[9].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[9].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[9].institutions[1].type | government |
| authorships[9].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[9].institutions[1].country_code | US |
| authorships[9].institutions[1].display_name | United States Food and Drug Administration |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Kelly E. Mercer |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Division of Systems Biology, National Center for Toxicological Research United States Food and Drug Administration Jefferson Arkansas USA |
| authorships[10].author.id | https://openalex.org/A5077240172 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-8318-5554 |
| authorships[10].author.display_name | Hang Xie |
| authorships[10].countries | US |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[10].affiliations[0].raw_affiliation_string | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| authorships[10].institutions[0].id | https://openalex.org/I1318287680 |
| authorships[10].institutions[0].ror | https://ror.org/02nr3fr97 |
| authorships[10].institutions[0].type | facility |
| authorships[10].institutions[0].lineage | https://openalex.org/I1299022934, https://openalex.org/I1318287680, https://openalex.org/I1320320070 |
| authorships[10].institutions[0].country_code | US |
| authorships[10].institutions[0].display_name | Center for Biologics Evaluation and Research |
| authorships[10].institutions[1].id | https://openalex.org/I1320320070 |
| authorships[10].institutions[1].ror | https://ror.org/034xvzb47 |
| authorships[10].institutions[1].type | government |
| authorships[10].institutions[1].lineage | https://openalex.org/I1299022934, https://openalex.org/I1320320070 |
| authorships[10].institutions[1].country_code | US |
| authorships[10].institutions[1].display_name | United States Food and Drug Administration |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Hang Xie |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research United States Food and Drug Administration Silver Spring Maryland USA |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70506 |
| open_access.oa_status | hybrid |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Dissecting Sex‐Specific Pathology in K18‐hACE2 Transgenic Mice Infected With Different SARS‐CoV‐2 Variants |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10118 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2725 |
| primary_topic.subfield.display_name | Infectious Diseases |
| primary_topic.display_name | SARS-CoV-2 and COVID-19 Research |
| related_works | https://openalex.org/W2196456463, https://openalex.org/W2357948923, https://openalex.org/W4313472242, https://openalex.org/W2332159055, https://openalex.org/W2030500189, https://openalex.org/W2419188526, https://openalex.org/W2144422987, https://openalex.org/W2018938924, https://openalex.org/W3171722058, https://openalex.org/W3156068899 |
| cited_by_count | 0 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1002/jmv.70506 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S49828768 |
| best_oa_location.source.issn | 0146-6615, 1096-9071 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0146-6615 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Journal of Medical Virology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70506 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Journal of Medical Virology |
| best_oa_location.landing_page_url | https://doi.org/10.1002/jmv.70506 |
| primary_location.id | doi:10.1002/jmv.70506 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S49828768 |
| primary_location.source.issn | 0146-6615, 1096-9071 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0146-6615 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Medical Virology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jmv.70506 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Medical Virology |
| primary_location.landing_page_url | https://doi.org/10.1002/jmv.70506 |
| publication_date | 2025-07-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3214495208, https://openalex.org/W4301391821, https://openalex.org/W3137661000, https://openalex.org/W4394019215, https://openalex.org/W3164269203, https://openalex.org/W3133819123, https://openalex.org/W4304701143, https://openalex.org/W4400467426, https://openalex.org/W4225004560, https://openalex.org/W3080487846, https://openalex.org/W4200011477, https://openalex.org/W3116815810, https://openalex.org/W4285031401, https://openalex.org/W3047144258, https://openalex.org/W3165997323, https://openalex.org/W4210916316, https://openalex.org/W3014067025, https://openalex.org/W3174731125, https://openalex.org/W3013800395, https://openalex.org/W3043431476, https://openalex.org/W4225083529, https://openalex.org/W4383704089, https://openalex.org/W4400521836, https://openalex.org/W2043343078, https://openalex.org/W3080378920, https://openalex.org/W4308261363, https://openalex.org/W3214110703, https://openalex.org/W4324129885, https://openalex.org/W4229009692, https://openalex.org/W4388902498, https://openalex.org/W3134228310, https://openalex.org/W2774613143, https://openalex.org/W3199099840, https://openalex.org/W3208677062, https://openalex.org/W2951569645, https://openalex.org/W4399879586, https://openalex.org/W4379511608, https://openalex.org/W4224282043, https://openalex.org/W4399732671, https://openalex.org/W3193641425, https://openalex.org/W4311283835, https://openalex.org/W4390636770, https://openalex.org/W3105908160, https://openalex.org/W4200190970, https://openalex.org/W3085365057, https://openalex.org/W2772088864, https://openalex.org/W4297911734, https://openalex.org/W4398139581, https://openalex.org/W2020055521, https://openalex.org/W2914381860, https://openalex.org/W4395115142, https://openalex.org/W4200477965 |
| referenced_works_count | 52 |
| abstract_inverted_index.+ | 96, 124 |
| abstract_inverted_index.T | 125 |
| abstract_inverted_index.a | 199 |
| abstract_inverted_index.G, | 44, 68 |
| abstract_inverted_index.In | 16 |
| abstract_inverted_index.NK | 97 |
| abstract_inverted_index.as | 110, 198 |
| abstract_inverted_index.by | 65 |
| abstract_inverted_index.in | 3, 6, 37, 59, 74 |
| abstract_inverted_index.of | 23, 41, 88, 102, 196 |
| abstract_inverted_index.or | 46 |
| abstract_inverted_index.to | 8, 77, 155, 188 |
| abstract_inverted_index.614 | 43, 67 |
| abstract_inverted_index.CD4 | 123 |
| abstract_inverted_index.Sex | 72 |
| abstract_inverted_index.and | 20, 26, 57, 62, 94, 104, 113, 131, 159, 174, 192 |
| abstract_inverted_index.are | 12 |
| abstract_inverted_index.for | 33, 202 |
| abstract_inverted_index.had | 120, 150, 164 |
| abstract_inverted_index.not | 13 |
| abstract_inverted_index.sex | 197 |
| abstract_inverted_index.the | 53, 66, 182, 194 |
| abstract_inverted_index.Lung | 142 |
| abstract_inverted_index.cell | 126, 175 |
| abstract_inverted_index.data | 145 |
| abstract_inverted_index.gene | 152 |
| abstract_inverted_index.host | 75 |
| abstract_inverted_index.lung | 63, 106, 122, 134 |
| abstract_inverted_index.male | 27 |
| abstract_inverted_index.mice | 30 |
| abstract_inverted_index.most | 54 |
| abstract_inverted_index.such | 109 |
| abstract_inverted_index.than | 115, 140 |
| abstract_inverted_index.that | 147 |
| abstract_inverted_index.then | 69 |
| abstract_inverted_index.this | 17, 179 |
| abstract_inverted_index.well | 14 |
| abstract_inverted_index.were | 31, 80 |
| abstract_inverted_index.with | 168, 186 |
| abstract_inverted_index.Delta | 50, 138 |
| abstract_inverted_index.Ly6G+ | 92 |
| abstract_inverted_index.Taken | 177 |
| abstract_inverted_index.after | 39, 128, 137 |
| abstract_inverted_index.cells | 98 |
| abstract_inverted_index.early | 100 |
| abstract_inverted_index.lungs | 19 |
| abstract_inverted_index.males | 83, 163 |
| abstract_inverted_index.nasal | 21, 60 |
| abstract_inverted_index.onset | 101 |
| abstract_inverted_index.study | 180 |
| abstract_inverted_index.while | 162 |
| abstract_inverted_index.CD163+ | 89 |
| abstract_inverted_index.Delta, | 45 |
| abstract_inverted_index.cavity | 61 |
| abstract_inverted_index.during | 99 |
| abstract_inverted_index.factor | 201 |
| abstract_inverted_index.female | 25 |
| abstract_inverted_index.immune | 157 |
| abstract_inverted_index.males. | 141 |
| abstract_inverted_index.matrix | 170 |
| abstract_inverted_index.severe | 55 |
| abstract_inverted_index.showed | 84 |
| abstract_inverted_index.study, | 18 |
| abstract_inverted_index.IL‐6, | 112 |
| abstract_inverted_index.IP‐10 | 114 |
| abstract_inverted_index.MCP‐1 | 135 |
| abstract_inverted_index.Omicron | 47, 70, 129 |
| abstract_inverted_index.complex | 183 |
| abstract_inverted_index.females | 119, 149 |
| abstract_inverted_index.humoral | 156 |
| abstract_inverted_index.induced | 52 |
| abstract_inverted_index.related | 154 |
| abstract_inverted_index.respect | 187 |
| abstract_inverted_index.spatial | 143 |
| abstract_inverted_index.ABSTRACT | 0 |
| abstract_inverted_index.IL‐10, | 111 |
| abstract_inverted_index.Overall, | 49 |
| abstract_inverted_index.cavities | 22 |
| abstract_inverted_index.dynamics | 185 |
| abstract_inverted_index.elevated | 105, 133 |
| abstract_inverted_index.enriched | 151, 165 |
| abstract_inverted_index.females. | 117 |
| abstract_inverted_index.followed | 64 |
| abstract_inverted_index.outcomes | 5 |
| abstract_inverted_index.pathways | 153, 166 |
| abstract_inverted_index.relation | 7 |
| abstract_inverted_index.response | 158 |
| abstract_inverted_index.revealed | 146 |
| abstract_inverted_index.variant. | 48, 71 |
| abstract_inverted_index.variants | 11, 191 |
| abstract_inverted_index.“M2” | 90 |
| abstract_inverted_index.NKR‐P1C | 95 |
| abstract_inverted_index.chemokine | 172 |
| abstract_inverted_index.collected | 32 |
| abstract_inverted_index.cytokines | 108 |
| abstract_inverted_index.increased | 85, 121 |
| abstract_inverted_index.infection | 40, 51, 79, 130, 139, 184 |
| abstract_inverted_index.pathology | 38, 58 |
| abstract_inverted_index.pulmonary | 86 |
| abstract_inverted_index.responses | 76 |
| abstract_inverted_index.secretion | 136 |
| abstract_inverted_index.together, | 178 |
| abstract_inverted_index.COVID‐19 | 4, 203 |
| abstract_inverted_index.associated | 167 |
| abstract_inverted_index.dissecting | 34 |
| abstract_inverted_index.highlights | 181 |
| abstract_inverted_index.importance | 195 |
| abstract_inverted_index.individual | 9, 189 |
| abstract_inverted_index.infection, | 103 |
| abstract_inverted_index.interferon | 160 |
| abstract_inverted_index.pathology. | 204 |
| abstract_inverted_index.signaling, | 161, 173 |
| abstract_inverted_index.transgenic | 29 |
| abstract_inverted_index.Conversely, | 118 |
| abstract_inverted_index.K18‐hACE2 | 28 |
| abstract_inverted_index.chemotaxis. | 176 |
| abstract_inverted_index.confounding | 200 |
| abstract_inverted_index.differences | 2, 36, 73 |
| abstract_inverted_index.production, | 171 |
| abstract_inverted_index.recruitment | 127 |
| abstract_inverted_index.underscores | 193 |
| abstract_inverted_index.understood. | 15 |
| abstract_inverted_index.Sex‐biased | 1 |
| abstract_inverted_index.infiltration | 87 |
| abstract_inverted_index.inflammation | 56 |
| abstract_inverted_index.inflammatory | 107 |
| abstract_inverted_index.macrophages, | 91 |
| abstract_inverted_index.neutrophils, | 93 |
| abstract_inverted_index.age‐matched | 24 |
| abstract_inverted_index.extracellular | 169 |
| abstract_inverted_index.significantly | 132 |
| abstract_inverted_index.SARS‐CoV‐2 | 10, 42, 78, 190 |
| abstract_inverted_index.sex‐specific | 35 |
| abstract_inverted_index.transcriptomics | 144 |
| abstract_inverted_index.Delta‐infected | 82, 116, 148 |
| abstract_inverted_index.variant‐specific. | 81 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5899999737739563 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.35764741 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |